MRI-guided Focal Laser Ablation for Prostate Cancer Treatment
Prostate cancer is one of the most common malignancies in males and has now become the second leading cause of cancer mortality. Prostate cancer diagnosis has increased from 3.9% to 8.2% of the population in the past decade. Approximately 52,300 new cases of prostate cancer are diagnosed in the United Kingdom every year, which is more than 140 every day. In this study, a robotic platform used for MRI-guided prostate therapy, including both biopsy and ablation, will be developed and validated. Compared with all the listed MR-safe robot platforms, the presented design will have a compact size, allowing it to be placed inside the scanner quickly. Moreover, the use of pneumatic stepper actuators will reduce the affection of EMI generated by piezoelectric motors and all the other parts are made of plastic, making the whole system to be MR safe.